Alzamend Neuro to Present at the 12th Annual LD Micro Invitational

Author's Avatar
Jun 03, 2022

Alzamend+Neuro%2C+Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, today announced that it will be presenting at the 12th Annual LD Micro Invitational, a three-day investor conference that is being held from June 7th to the 9th at the Four Seasons in Westlake Village, California.